Oesophageal Doppler monitoring, doubt and equipoise: Evidence based medicine means change

Anaesthesia

Volumn 68, Issue 7, 2013, Pages 684-688

  Morris, C ^a  

^a ROYAL DERBY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ALBUMIN; HETASTARCH; STEROID;

ANESTHESIST; BETA ADRENERGIC RECEPTOR BLOCKING; COLLOID; EPIDURAL ANESTHESIA; EQUIPOISE; ESOPHAGEAL DOPPLER MONITORING; EVIDENCE BASED MEDICINE; HEAD INJURY; HEART CATHETERIZATION; HUMAN; MAJOR SURGERY; MEDICAL DECISION MAKING; MONITORING; RENAL REPLACEMENT THERAPY; REVIEW; SEPSIS;

ESOPHAGUS; EVIDENCE-BASED MEDICINE; HUMANS; INDIVIDUALIZED MEDICINE; MONITORING, INTRAOPERATIVE; PROTEIN C; SURGICAL PROCEDURES, OPERATIVE; THERAPEUTIC EQUIPOISE;

EID: 84879101695     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/anae.12306     Document Type: Review

References (51)

1. Morris CG, Russell C,. Morbidity and mortality after emergency surgery. British Medical Journal 2006; 333: 713-4.
2. Campbell B,. Innovation, NICE and CardioQ. British Journal of Anaesthesia 2012; 108: 726-9.
3. Deltex Medical. Where there's flow there's life. http://www. deltexmedical.com/downloads/ODMBrochure.pdf (accessed 18/03/2013).
4. Campbell B, Longson C,. Oesophageal Doppler monitoring: the role of NICE. Anaesthesia 2012; 67: 430-1.
5. Agency for Healthcare Research and Quality. Esophageal Doppler ultrasound-based cardiac output monitoring for real-time therapeutic management of hospitalized patients: a review. http://www.cms.gov/Medicare/Coverage/ DeterminationProcess/downloads/id45TA.pdf (accessed 18/03/2013).
6. Morris CG, Gold S,. Enhanced recovery programmes; coming to a hospital near you!. Anaesthesia 2011; 66: 864-8.
7. Ghosh S, Arthur B, Klein AA,. NICE guidance on CardioQ™ oesophageal Doppler monitoring. Anaesthesia 2011; 66: 1081-3.
8. Pandit JJ, Cook TM,. National Institute for Clinical Excellence guidance on measuring depth of anaesthesia: limitations of EEG-based technology. British Journal of Anaesthesia 2013; 110: 325-8.
9. Cochrane Injuries Group Albumin Reviewers. Why albumin may not work. British Medical Journal 1998; 317: 235-40.
10. SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. New England Journal of Medicine 2004; 350: 2247-56.
11. Gattinoni L,. Albumin in severe sepsis and septic shock: the ALBIOS study. http://air.unimi.it/handle/2434/169824 (accessed 18/03/2013).
12. Dellinger RP, Levy MM, Rhodes A, et al, for the Surviving Sepsis Campaign Guidelines Group. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2012. Critical Care Medicine 2013; 41: 580-637.
13. Soni N,. ARDS, acronyms and the Pinocchio effect. Anaesthesia 2010; 65: 971-9.
14. McGauran N, Wiesler B, Kresi J, Schüler YB, Kölsch H, Kaiser T,. Reporting bias in medical research-a narrative review. Trials 2010; 11: 37.
15. Song F, Parekh-Bhurke S, Hooper L, et al. Extent of publication bias in different categories of research cohorts: a meta-analysis of empirical studies. BMC Medical Research Methodology 2009; 9: 79.
16. Goldhill D, Waldmann C,. Evidence-based critical care medicine: seeing through a glass darkly. Anaesthesia 2011; 66: 73-83.
17. Bernard G, Vincent JL, Laterre PF, et al., for the PROWESS Study Group. Efficacy and safety of recombinant human activated protein C for severe sepsis. New England Journal of Medicine 2001; 344: 699-709.
18. Vincent JL, Angus DC, Artigas A, et al., for the PROWESS Study Group. Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial. Critical Care Medicine 2003; 31: 834-40.
19. Morris C,. Activated Protein C in the treatment of sepsis. Anaesthesia 2002; 57: 502-4.
20. Abraham E, Laterre PF, Garg R, et al., for the ADDRESS Study Group. Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. New England Journal of Medicine 2005; 353: 1332-41.
21. Friedrich JO,. Drotrecogin alfa (activated) in severe sepsis. New England Journal of Medicine 2006; 354: 94-6.
22. Ranieri VM, Thompson TB, Barie SP, et al, for the PROWESS-SHOCK Study Group. Drotrecogin alfa (activated) in adults with septic shock. New England Journal of Medicine 2012; 366: 2055-64.
23. Harvey S, Harrison DA, Singer M, et al., for the PAC-Man Study Collaboration. Assessment of the clinical effectiveness of pulmonary artery catheters in management of patients in intensive care (PAC-Man): a randomised controlled trial. Lancet 2005; 366: 472-7.
24. Abbas SM, Hill AG,. Systematic review of the literature for the use of oesophageal Doppler monitor for fluid replacement in major abdominal surgery. Anaesthesia 2008; 63: 44-51.
25. Price JD, Sear JJW, Venn RRM,. Perioperative fluid volume optimization following proximal femoral fracture. Cochrane Database of Systematic Reviews 2008; 4: CD003004.
26. Rahbari NN, Zimmermann JB, Schmidt T, et al. Meta-analysis of standard, restrictive and supplemental fluid administration in colorectal surgery. British Journal of Surgery 2009; 96: 331-41.
27. Srinivasa S, Taylor MH, Sammour T, et al. Oesophageal Doppler-guided fluid administration in colorectal surgery: critical appraisal of published clinical trials. Acta Anaesthesiologica Scandinavia 2011; 55: 4-13.
28. Kuper M, Gold SJ, Callow C, et al. Intraoperative fluid management guided by oesophageal Doppler monitoring. British Medical Journal 2011; 24: 342.
29. Woodcock T,. Oesophageal Doppler monitoring: premature guidance and what about the fluids? Anaesthesia 2012; 67: 425.
30. Ghuman N, Griffiths R,. Oesophageal Doppler monitoring: evidence and hip surgery. Anaesthesia. 2012; 67: 425-6.
31. Minto G, Struthers R,. Oesophageal Doppler monitoring: costly and supported by weak evidence. Anaesthesia 2012; 67: 426-7.
32. Nesbitt ID, Cosgrove JF, Berridge JC,. Oesophageal Doppler monitoring: a misguided editorial. Anaesthesia 2012; 67: 427-8.
33. Singer M,. Oesophageal Doppler monitoring: a not-so-NICE editorial. Anaesthesia 2012; 67: 428-30.
34. Ghosh S, Arthur B, Klein AA,. NICE guidance on CardioQ™ oesophageal Doppler monitoring: author's reply. Anaesthesia 2012; 67: 431-2.
35. National Institute for Health and Clinical Excellence. CardioQ-ODM oesophageal Doppler monitor. Medical Technology Guide 3, March 2011. http://www.nice.org.uk/nicemedia/live/13312/52624/52624.pdf (accessed 18/03/2013).
36. Mowatt G, Houston G, Hernandez, et al. Systematic review of the clinical effectiveness and cost-effectiveness of oesophageal Doppler monitoring in critically ill and high-risk surgical patients. Health Technology Assessment 2009; 13: No. 7.
37. University College London Hospitals. Device pioneered at UCLH to improve patient care. http://www.uclh.nhs.uk/News/Pages/ DevicepioneeredatUCLHtoimprovepatientcare.aspx (accessed 18/03/2013).
38. Skorzyński W, Jakiel G, Przesmycki K,. Haemodynamics during gynaecological laparoscopy. Anaesthesiology Intensive Therapy 2008; 40: 7-12.
39. Morris CG, Boyd A, Reynolds N,. Should we really be more 'balanced' in our fluid prescribing? Anaesthesia 2009; 64: 703-5.
40. Myburgh JA, Finfer S, Bellomo R, et al., for the CHEST Investigators. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. New England Journal of Medicine 2012; 367: 1901-11.
41. Grocott MPW, Dushianthan A, Hamilton MA, Mythen MG, Harrison D, Rowan K, Optimisation Systematic Review Steering Group. Perioperative increase in global blood flow to explicit defined goals and outcomes following surgery. Cochrane Database of Systematic Reviews 2012; 11: CD004082.
42. Pearse R, Dawson D, Fawcett J, Rhodes A, Grounds RM, Bennett ED,. Early goal-directed therapy after major surgery reduces complications and duration of hospital stay. A randomised, controlled trial. Critical Care 2005; 9: R687-93.
43. Morris C, Rogerson D,. What is the optimal type of fluid to be used for peri-operative fluid optimisation directed by oesophageal Doppler monitoring? Anaesthesia 2011; 66: 819-27.
44. Brunkhorst FM, Engel C, Bloos F, et al, for the SEPNet Group. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. New England Journal of Medicine 2008; 358: 125-39.
45. Perner A, Haasse N, Guttormsen AB, et al., for the 6S Study Group. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. New England Journal of Medicine 2012; 367: 124-34.
46. Senagore AJ, Emery T, Luchtefeld M, Kim D, Dujovny N, Hoedema R,. Fluid management for laparoscopic colectomy: a prospective, randomized assessment of goal-directed administration of balanced salt solution or hetastarch coupled with an enhanced recovery program. Diseases of the Colon and Rectum 2009; 52: 1935-40.
47. Challand C, Struthers R, Sneyd JR, et al. Randomized controlled trial of intraoperative goal-directed fluid therapy in aerobically fit and unfit patients having major colorectal surgery. British Journal of Anaesthesia 2012; 108: 53-62.
48. Brandstrup B, Svendsen PE, Rasmussen M, et al. Which goal for fluid therapy during colorectal surgery is followed by the best outcome: near-maximal stroke volume or zero fluid balance? British Journal of Anaesthesia 2012; 109: 191-9.
49. Griffiths R, Alper J, Beckingsale A, et al. Management of proximal femoral fractures 2011. Anaesthesia 2012; 67: 85-98.
50. Sinclair S, Singer M,. Intraoperative intravascular volume optimisation and length of hospital stay after repair of proximal femoral fracture: randomised controlled trial. British Medical Journal 1997; 315: 909-12.
51. Venn R, Steele A, Richardson P, Poloniecki J, Grounds M, Newman P,. Randomized controlled trial to investigate influence of the fluid challenge on duration of hospital stay and perioperative morbidity in patients with hip fractures. British Journal of Anaesthesia 2002; 88: 65-71.